Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-02-09 00:00:00 ET · period of report 2022-02-07 · accession 0001209191-22-008126 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-09 | 2022-02-07 | KPTI | Mason Michael | EVP, CFO, Treas | S - Sale | $9.86 | -3,947 | 53.3K | -7% | -$38.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-07 | S | D | 3,947 | $9.86 | 53,308 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 7, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees. |